Insulin transport from plasma into the central nervous system is inhibited by dexamethasone in dogs

Diabetes

Volumn 45, Issue 1, 1996, Pages 86-90

  Baura, Gail D ^a   Foster, David M ^a   Kaiyala, Karl ^b   Porte Jr , Daniel ^b   Kahn, Steven E ^b   Schwartz, Michael W ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; HALOTHANE; INSULIN; INSULIN RECEPTOR; THIAMYLAL;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; CENTRAL NERVOUS SYSTEM; COMPARTMENT MODEL; CONTROLLED STUDY; DOG; HORMONE TRANSPORT; INSULIN BINDING; INSULIN BLOOD LEVEL; INSULIN INFUSION; INSULIN METABOLISM; INTRACISTERNAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MATHEMATICAL MODEL; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TRANSCYTOSIS; TRANSPORT KINETICS;

EID: 0030069591     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.1.86     Document Type: Article

References (28)

1. Baura GD, Foster DM, Porte D Jr, Kahn SE, Bergman RN, Cobelli C, Schwartz MW: Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. J Clin Invest 92:1824-1830, 1993
2. King GL, Johnson SM: Receptor-mediated transport of insulin across endothelial cells. Science 277:1583-1586, 1985
3. Bagdade JD, Bierman EL, Porte D Jr The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest 46:1549-1557, 1967
4. Perley M, Kipnis DM: Effect of glucocorticoids on plasma insulin. N Engl J Med 274:1237-1241, 1966
5. Pagano G, Cavallo-Perin P, Cassader M, Bruno A, Ozzello A, Masciola P, Dall'omo AM, Imbimbo B: An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J Clin Invest 72.1814-1820, 1983
6. Rizza RA, Mandarino LJ, Gerich JE: Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor defect of insulin action. J Clin Endocrinol Metab 54:131-138, 1982
7. Nosadim R, Del Prato S, Tiengo A, Valerio A, Muggeo M, Opocher G, Mantero F, Duner E, Marescotti C, Mollo F, Belloni F: Insulin resistance in Cushing's syndrome. J Clin Endocrinol Metab 57:529-530, 1983
8. Amatruda JM, Livingston JN, Lockwood DH: Cellular mechanisms in selected states of insulin resistance: human obesity, glucocorticoid excess, and chronic renal failure. Diabetes Metab Rev 1:293-317, 1985
9. Haber RS, Weinstein SP: Role of glucose transporters in glucocorticoid-induced insulin resistance Diabetes 41:728-735, 1992
10. Pollay M: Pharmacological manipulation of cerebrospinal fluid secretion. In Barriers and Fluids of the Eye and Brain. Segal MB, Ed. Boston, CRC, 1992, p. 49-58
11. Weiss MH, Nulsen FE: The effect of glucocorticoids on CSF flow in dogs. J Neurosurg 32:402-458, 1970
12. Sato O, Hara M, Asai T, Tsugane R, Kageyama N: The effect of dexamethasone phosphate on the production rate of cerebrospinal fluid in the spinal subarachnoid space of dogs. J Neurosurg 39:480-484, 1973
13. Amano Y: The cerebrospinal fluid production rate in the experimentally induced edematous brain and influences of dexamethasone upon it. Nagoya J Med Sci 31.427-441, 1969
14. Schwartz MW, Bergman RN, Kahn SE, Taborsky GJ Jr, Fisher LD, Sipols AJ, Woods SC, Steil GM, Porte D Jr. Evidence for entry of plasma insulin into cerebrospinal fluid through an intermediate compartment in dogs J Clin Invest 88:1272-1281, 1991
15. Berman M, Weiss MF: The SAAM Manual. Washington DC. U.S. Govt. Printing Office (DHEW publ. no (NIH) 78-180, 1978)
16. Reed DJ, Woodbury DM Kinetics of movement of iodide, sucrose, inulin and radio-iodinated serum albumin in the central nervous system and cerebrospinal fluid of the rat. J Physiol 169:816-850, 1963
17. Davson H. Physiology of the Cerebrospinal Fluid. London, Churchill, 1970
18. Gilman AG, Rall TW, Nies AS, Taylor P (Eds.): Goodman and Gilman's The Pharmacological Basis of Therapeutics 8th ed. New York, Pergamon, 1990. p 21
19. Lee A, Ader M, Bray GA, Bergman RN: Diurnal variation in glucose tolerance. Diabetes 41:750-759, 1992
20. Yalow RS, Eng J: Insulin in the central nervous system. Adv Metab Disord 10:341-354, 1983
21. Pardridge WM: Receptor-mediated transport through the blood-brain barrier. Endocr Rev 7:314-330, 1987
22. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte D Jr Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev 13.387-414, 1992
23. Duffy KR, Pardndge WM. Blood-brain barrier transcytosis of insulin in developing rabbits. Brain Res 420:32-38, 1987
24. Wood JH: Physiology, pharmacology and dynamics of CSF. In Neurobiology of Cerebrospinal Fluid. Wood JH, Ed. New York, Plenum, 1980, p. 3
25. Woods SC, Figlewicz Lattemmann DP, Schwartz MW, Porte D Jr A re-assessment of the regulation of adiposity and appetite by the brain insulin system. Int J Obes 14 (Suppl. 3):69-76, 1990
26. Hollifield G: Glucocorticoid-induced obesity: a model and a challenge. Am J Clin Nutr 21:1471-1474, 1968
27. Green PK, Wilkinson CW, Woods SC: Intraventricular corticosterone increases the rate of body weight gain in underweight adrenalectomized rats. Endocrinology 130:269-275, 1992
28. Yang YJ, Hope ID, Ader M, Bergman RN Insulin transport across capillaries is rate limiting for insulin action in dogs. J Clin Invest 84:1620-1628, 1989